Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 4:13:979248.
doi: 10.3389/fendo.2022.979248. eCollection 2022.

Effect of calcium ionophore (A23187) on embryo development and its safety in PGT cycles

Affiliations

Effect of calcium ionophore (A23187) on embryo development and its safety in PGT cycles

Junya Zhang et al. Front Endocrinol (Lausanne). .

Abstract

Background: Intracytoplasmic sperm injection (ICSI) has tremendous advantages for resolving the problem of male infertility. However, ICSI fertilization can fail in some patients because of various reasons, primarily because of the failure of oocyte activation. Oocytes have been activated using calcium ionophore (A23187) in previous clinical cases of ICSI fertilization failure. However, studies on the efficiency of calcium ionophore (A23187) activation, its effects on the developmental potential of embryos, and its effects on pregnancy outcomes after embryo transfer are relatively limited.

Methods: In this study, we investigated the safety and long-term efficacy of calcium ionophore (A23187) by analyzing its effects on fertilization, embryonic development, aneuploidy, and pregnancy outcomes in patients undergoing preimplantation genetic testing (PGT) cycles.

Results: Comparative analyses of the activation followed by PGT (A-PGT) and PGT groups revealed no significant differences between the oocyte cleavage rate and high-quality embryo rate (98.19% vs. 98.63% and 63.13% vs. 68.39%, respectively, p > 0.05). Although the blastocyst formation rate was significantly lower in the A-PGT group than that in the PGT group (52.22% vs. 59.90%, p < 0.05), no significant difference was observed in the blastocyst aneuploidy rates of the two groups (24.49% vs. 24.55%, p > 0.05). Furthermore, no significant differences were observed between the two groups in terms of the live birth rate (43.75% vs. 52.99%), week of delivery, and birth weight of the infants after transfer of euploid blastocysts (p > 0.05). Furthermore, the 2PN rate, oocyte cleavage rate, blastocyst formation rate, and live birth rate were found to be significantly lower in the A-ICSI group than those in the ICSI group (p < 0.01), but there was no significant difference between the two groups in the week of delivery and birth weight of live births (p > 0.05).

Discussion: These results suggest that the use of calcium ionophore (A23187) activation as an option in cases of ICSI fertilization failure does not affect the ploidy of developing blastocysts and has no significant effects on the week of delivery or birth weight after transfer. Thus, we provide a scientific basis for the clinical safety of oocyte activation using calcium ionophore (A23187).

Keywords: calcium ionophore (A23187); chromosome aneuploidy; embryo development potential; fertilization failure; pregnancy outcome.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Comparative analysis of the chromosomal status of blastocysts in patients between the PGT and A-PGT group. Bars in the graph indicate percentages. Normal karyotype: 46, XX or 46, XY. Gain, increased copy number of the entire chromosome. Loss, at least one entire chromosome is missing. Dup, duplication of a chromosomal fragment. Del, loss of a chromosomal fragment. Upd, uniparental diploidy. Mos, mosaicism. MA, Multiple chromosomal abnormalities containing both duplication or deletion of chromosomal segments and mosaicism. NS indicates no statistically significant difference between the two groups.

Similar articles

Cited by

References

    1. Rosenwaks Z, Pereira N. The pioneering of intracytoplasmic sperm injection: historical perspectives. Reproduction (2017) 154(6):F71–7. doi: 10.1530/REP-17-0308 - DOI - PubMed
    1. Yeste M, Jones C, Amdani SN, Patel S, Coward K. Oocyte activation deficiency: A role for an oocyte contribution? Hum Reprod Update (2016) 22(1):23–47. doi: 10.1093/humupd/dmv040 - DOI - PubMed
    1. Sanders JR, Swann K. Molecular triggers of egg activation at fertilization in mammals. Reproduction (2016) 152(2):R41–50. doi: 10.1530/REP-16-0123 - DOI - PubMed
    1. Mu J, Zhang Z, Wu L, Fu J, Chen B, Yan Z, et al. The identification of novel mutations in PLCZ1 responsible for human fertilization failure and a therapeutic intervention by artificial oocyte activation. Mol Hum Reprod (2020) 26(2):80–7. doi: 10.1093/molehr/gaaa003 - DOI - PubMed
    1. Kashir J, Nomikos M, Lai FA. Phospholipase C zeta and calcium oscillations at fertilisation: The evidence, applications, and further questions. Adv Biol Regul (2018) 67:148–62. doi: 10.1016/j.jbior.2017.10.012 - DOI - PubMed

Publication types